Tenecteplase or alteplase: what is the thrombolytic agent of the future?

Mahmood, A. and Muir, K. W. (2022) Tenecteplase or alteplase: what is the thrombolytic agent of the future? Current Treatment Options in Neurology, 24(10), pp. 503-513. (doi: 10.1007/s11940-022-00733-4) (PMID:35965955) (PMCID:PMC9362569)

[img] Text
275201.pdf - Published Version
Available under License Creative Commons Attribution.



Purpose of review: Alteplase has been the thrombolytic of choice for acute ischaemic stroke for more than two decades. A thrombolytic which is easier to administer and with improved or comparable safety and efficacy is desirable. Tenecteplase has emerged as a potential successor, and its off-license use in acute ischaemic stroke has increased in recent years. We aimed to examine the evidence base for each drug and discuss their use in varying patient populations in acute ischaemic stroke. Recent findings: Several trials comparing tenecteplase and alteplase have reported very recently with the results of the ACT trial strengthening the argument in favour of non-inferiority of tenecteplase to alteplase. Ongoing trials such as ATTEST-2 are of interest, and trials such as TASTE and TEMPO-2 will shed further light on use of tenecteplase in specific populations. Summary: A single thrombolytic agent for all indications for thrombolysis in acute ischaemic stroke is desirable in streamlining workflows. Based on recent and upcoming trials, guidelines may soon recommend tenecteplase as a suitable alternative to alteplase. The use of tenecteplase in specific subgroups will depend on further recruitment to ongoing clinical trials.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Muir, Professor Keith and Mahmood, Dr Ammad
Authors: Mahmood, A., and Muir, K. W.
College/School:College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience
Journal Name:Current Treatment Options in Neurology
ISSN (Online):1534-3138
Published Online:30 July 2022
Copyright Holders:Copyright © 2022 The Authors
First Published:First published in Current Treatment Options in Neurology 24(10): 503-513
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
172252ATTEST 2: Alteplase-Tenecteplase Thrombolysis Efficacy in Stroke ThrombolysisIan FordStroke Association (STROKEAS)TSA BHF 2015/01School of Psychology and Neuroscience